Minerva Neurosciences ... for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

StockNews.com began coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a report released on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock.